Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 32
2015 252
2016 356
2017 320
2018 307
2019 314
2020 343
2021 291
2022 311
2023 285
2024 130

Text availability

Article attribute

Article type

Publication date

Search Results

2,586 results

Results by year

Filters applied: . Clear all
Page 1
Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial.
Mayer KH, Molina JM, Thompson MA, Anderson PL, Mounzer KC, De Wet JJ, DeJesus E, Jessen H, Grant RM, Ruane PJ, Wong P, Ebrahimi R, Zhong L, Mathias A, Callebaut C, Collins SE, Das M, McCallister S, Brainard DM, Brinson C, Clarke A, Coll P, Post FA, Hare CB. Mayer KH, et al. Lancet. 2020 Jul 25;396(10246):239-254. doi: 10.1016/S0140-6736(20)31065-5. Lancet. 2020. PMID: 32711800 Free PMC article. Clinical Trial.
Tenofovir alafenamide fumarate.
Lee WA, Cheng AK. Lee WA, et al. Antivir Ther. 2022 Apr;27(2):13596535211067600. doi: 10.1177/13596535211067600. Antivir Ther. 2022. PMID: 35499175 Free article.
The use of tenofovir in patients with COVID-19.
Kow CS, Ramachandram DS, Hasan SS. Kow CS, et al. HIV Med. 2022 Aug;23(7):807-808. doi: 10.1111/hiv.13228. Epub 2022 Jan 12. HIV Med. 2022. PMID: 35023263 No abstract available.
Response to 'The use of tenofovir in patients with COVID-19'.
Lee MJ, Nori A, Fidler S, Kulasegaram R, Fox J, Smith C; RECEDE-C19 study. Lee MJ, et al. HIV Med. 2022 Sep;23(8):929-930. doi: 10.1111/hiv.13278. Epub 2022 Feb 22. HIV Med. 2022. PMID: 35194929 Free PMC article. No abstract available.
2,586 results